2006 Surveillance Slides
Completion of TB Therapy
United States, 1993–2004
| Slide 26. Completion of TB Therapy, United
States, 1993–2004. The
reporting areas began providing information on completion
of therapy in 1993 through the individual TB case report form.
The calculations exclude patients with an initial isolate
resistant to rifampin as well as children with meningeal,
bone or joint, or miliary disease. Overall completion of therapy
has remained at approximately 92% from 1998 through 2004.
Completion in 1 year or less increased from 64% in 1993 to
approximately 82% in 1998—2004, the latest year with
available data. The current DHHS Healthy People 2010 objective
is completion of therapy in 1 year or less in 90% of patients.
CDC is working with state and local health departments to
determine and evaluate reasons for apparently delayed completion
of therapy, which may vary by jurisdiction.
Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination - http://www.cdc.gov/tb
Please send comments/suggestions/requests
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333